FDA issues updated list of devices subject to tracking rules

03/31/2014 | Regulatory Focus

The FDA has released a document updating the list of devices that must be tracked under the final rule setting up a unique identifier system for medical technologies. The agency said it determines whether a device should be tracked based on the technology's potential for sudden, catastrophic failure; possibility for substantial adverse clinical outcomes; and the need for immediate professional intervention.

View Full Article in:

Regulatory Focus

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT